المؤلفون: Dal MS; Division of Hematology and Bone Marrow Transplantation Unit, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, 06200, Yenimahalle, Ankara, Turkey. dr.sinandal@gmail.com., Ulu BU; Division of Hematology and Bone Marrow Transplantation Unit, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, 06200, Yenimahalle, Ankara, Turkey., Uzay A; Hematology and Bone Marrow Transplant Unit, Atakent Hospital, Acibadem University, Istanbul, Turkey., Akay OM; Division of Hematology, Department of Internal Medicine, Koç University Medical School, Istanbul, Turkey., Beşışık S; Division of Hematology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Yenerel MN; Division of Hematology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey., Çelik S; Division of Hematology, Department of Internal Medicine, Erciyes University, Kayseri, Turkey., Kaynar L; Division of Hematology, Department of Internal Medicine, Istanbul Medipol University, Istanbul, Turkey., Yücel OK; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Deveci B; Hematology and Stem Cell Transplantation Unit, Medstar Antalya Hospital, Antalya, Turkey., Sönmez M; Division of Hematology, Department of Internal Medicine, Karadeniz Technical University, Trabzon, Turkey., Mehtap Ö; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey., Beköz HS; Division of Hematology, Department of Internal Medicine, Istanbul Medipol University, Istanbul, Turkey., Sunu C; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Sakarya University, Sakarya, Turkey., Salim O; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Akdeniz University, Antalya, Turkey., Ulaş T; Division of Hematology, School of Medicine, Department of Internal Medicine, Near East University, Nicosia, Cyprus., Kartı S; Hematology and Bone Marrow Transplant Unit, Atakent Hospital, Acibadem University, Istanbul, Turkey., Altuntaş F; Division of Hematology and Bone Marrow Transplantation Unit, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, 06200, Yenimahalle, Ankara, Turkey.; Division of Hematology, Department of Internal Medicine, School of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey., Ferhanoğlu B; Division of Hematology, Department of Internal Medicine, Koc University School of Medicine and V.K.V. American Hospital, Istanbul, Turkey., Tuğlular TF; Division of Hematology, Department of Internal Medicine, Marmara University, Istanbul, Turkey.

المصدر: Annals of hematology [Ann Hematol] 2023 Jan; Vol. 102 (1), pp. 133-140. Date of Electronic Publication: 2022 Nov 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Non-Hodgkin*/drug therapy , Immunoconjugates*/therapeutic use , Lymphoma, Large B-Cell, Diffuse*/pathology, Humans ; Rituximab/adverse effects ; Bendamustine Hydrochloride/adverse effects ; Turkey/epidemiology ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Ulu BU; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey. Electronic address: bahar.uncuulu@saglik.gov.tr., Başcı S; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Bakırtaş M; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yiğenoğlu TN; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Batgi H; Department of Hematology, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yıldız J; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Darçın T; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Şahin D; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Baysal NA; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., İskender D; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Çakar MK; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Dal MS; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Altuntaş F; Department of Hematology and Bone Marrow Transplantation, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

المصدر: Leukemia research [Leuk Res] 2022 Apr; Vol. 115, pp. 106810. Date of Electronic Publication: 2022 Feb 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: ABO Blood-Group System*/therapeutic use , Lymphoma, Large B-Cell, Diffuse*, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Humans ; Multivariate Analysis ; Prognosis ; Retrospective Studies ; Rituximab/therapeutic use

المؤلفون: Ulu BU; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey. Electronic address: baharuncu@gmail.com., Yiğenoğlu TN; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Başcı S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Bakırtaş M; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Şahin D; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Darçın T; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yaman S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Bozan E; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Seçilmiş S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Candır BA; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yıldız J; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., İskender D; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Baysal NA; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Çakar MK; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Dal MS; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Altuntaş F; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

المصدر: Leukemia research [Leuk Res] 2021 Nov; Vol. 110, pp. 106700. Date of Electronic Publication: 2021 Aug 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lymphoma, Large B-Cell, Diffuse/*mortality , Neoplasm Recurrence, Local/*mortality, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cyclophosphamide/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Prednisone/administration & dosage ; Prognosis ; Remission Induction ; Retrospective Studies ; Rituximab/administration & dosage ; Survival Rate ; Vincristine/administration & dosage ; Young Adult

المؤلفون: Başcı S; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Bakırtaş M; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yiğenoğlu TN; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Uncu Ulu B; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Batgi H; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yıldız J; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Dal MS; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Kızıl Çakar M; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Altuntaş F; Department of Hematology and Bone Marrow Transplantation Center, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

المصدر: Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2021 Aug; Vol. 10 (4), pp. 483-487. Date of Electronic Publication: 2020 Nov 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101543508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2156-535X (Electronic) Linking ISSN: 21565333 NLM ISO Abbreviation: J Adolesc Young Adult Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols* , Lymphoma, Large B-Cell, Diffuse*/drug therapy, Adolescent ; Child ; Cyclophosphamide ; Disease-Free Survival ; Doxorubicin/therapeutic use ; Humans ; Prednisone/therapeutic use ; Prognosis ; Retrospective Studies ; Rituximab/therapeutic use ; Vincristine/therapeutic use ; Young Adult

المؤلفون: Mert D; Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Merdin A; University of Health Sciences, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey., Ceken S; Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Dal MS; University of Health Sciences, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey., Ertek M; Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Altuntas F; University of Health Sciences, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.

المصدر: Journal of cancer research and therapeutics [J Cancer Res Ther] 2021 Jul-Sep; Vol. 17 (4), pp. 951-955.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print Cited Medium: Internet ISSN: 1998-4138 (Electronic) Linking ISSN: 19984138 NLM ISO Abbreviation: J Cancer Res Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Viral/*blood , HIV Infections/*complications , Hepatitis B/*complications , Hepatitis C/*complications , Hodgkin Disease/*epidemiology , Lymphoma, Large B-Cell, Diffuse/*epidemiology, Adult ; Antibodies, Viral/immunology ; Antigens, Viral/immunology ; Female ; Follow-Up Studies ; HIV/immunology ; HIV Infections/blood ; HIV Infections/virology ; Hepacivirus/immunology ; Hepatitis B/blood ; Hepatitis B/virology ; Hepatitis B virus/immunology ; Hepatitis C/blood ; Hepatitis C/virology ; Hodgkin Disease/blood ; Hodgkin Disease/immunology ; Hodgkin Disease/virology ; Humans ; Lymphoma, Large B-Cell, Diffuse/blood ; Lymphoma, Large B-Cell, Diffuse/immunology ; Lymphoma, Large B-Cell, Diffuse/virology ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Seroepidemiologic Studies ; Turkey/epidemiology

المؤلفون: Başcı S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey. Electronic address: dr.semihbasci@gmail.com., Yiğenoğlu TN; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Bakırtaş M; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Uncu Ulu B; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yaman S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Dal MS; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Kızıl Çakar M; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Altuntaş F; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

المصدر: Leukemia research [Leuk Res] 2021 Mar; Vol. 102, pp. 106521. Date of Electronic Publication: 2021 Feb 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse/*drug therapy , Lymphoma, Large B-Cell, Diffuse/*pathology, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; Cyclophosphamide ; Disease-Free Survival ; Doxorubicin ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse/mortality ; Male ; Middle Aged ; Prednisone ; Prognosis ; Rituximab ; Treatment Outcome ; Vincristine